Provision of Highest Quality Information

Safety Management and Regulatory Affairs System

Pharmaceuticals contribute to the health of people all over the world, and Daiichi Sankyo Vietnam has established internal systems to ensure a high level of safety management and regulatory affairs activities. It conducts ongoing training to make sure that each employee is aware of and adheres to the Company's safety policies. Daiichi Sankyo Vietnam exhaustively compiles safety management information (such as information on side effects) from around the world and provides accurate information on appropriate usage to medical professionals. Regulatory affairs acitivities ensure under compliance with relevant laws, local regulations and guidelines, as well as ethical and scientific aspects.

Provision of High-quality Information to Healthcare Professionals

Given that pharmaceuticals by nature have both benefits and risks that must be carefully balanced, it is important for pharmaceutical companies to generate high-quality information on their efficacy and safety, and to provide the information to the medical field in order to promote their proper use. In the early phase after the launch of a new drug, in particular, there is not a sufficient amount of information available to meet various needs in the medical practice, even though the efficacy and safety of the drug was confirmed in the development phase.

Through cooperation among relevant units, the Daiichi Sankyo Vietnam provided information relating to Pharmaceutical Products to healthcare professionals through medical journals, conference presentations, and proper use materials. Additionally, the company leverages digital platforms for medical education, such as xocotbenteoco.vn. Through these efforts, Daiichi Sankyo Vietnam is committed to promoting the proper use of medications and contributing to advancements in medical technology.

 High-quality information is information created under compliance with laws and regulations which possesses medical and scientific value. Therefore, we check compliance with relevant laws, regulations and guidelines, as well as ethical and scientific aspects, when promoting pharmaceutical products.

 Medical Affairs Division’s Activities

Since MA Unit launched a global MA structure in October 2017, a global medical plan for each product has been developed and activities related to creating and disseminating information based on the plan have been executed in globally with focus on the field of Oncology and the Specialty & Value Product.

Toward achieving the 2025 Vision, "MA unit strives to be a transformative strategic partner to deliver value-added medical solutions to enhance patient lives," the Unit works every day with the aim of being a partner who delivers optimal medical solutions to stakeholders who provide and receive healthcare, including healthcare professionals, patients, patients groups, etc. around the world, by maximizing the contribution in pharmaceutical treatment through activities to generate and disseminate highly valuable evidence for pharmaceutics that the Daiichi Sankyo Group delivers to the world.

In 2021, Daiichi Sankyo Vietnam launched Medical Affair function to handle prasugrel, edoxaban, methoxyflurane, edaranove, and other our value products for the generation and communication of accurate medical and scientific information externally and internally. Based on the study results, we will exchange medical and scientific information with external medical experts to identify clinical questions (questions of patients and people practicing medicine regarding the use of pharmaceuticals) and obtain new evidence by planning and promoting company-initiated study programs for investigating such questions. We will thus promote activities to create and disseminate information needed by patients and people practicing medicine.

CSR in Vietnam

Technical Cooperation for MR Vaccine Production in Vietnam

For five years until March 2018, Daiichi Sankyo Biotech Co., Ltd. (formerly, Kitasato Daiichi Sankyo Vaccine) cooperated with the Japan International Cooperation Agency (JICA) for the Vietnam POLYVAC* "Measles-Rubella (MR) Vaccine Production Technology Transfer Project."

This activity enabled Vietnam to produce safe and reliable MR vaccine in the country without relying on imported ones.
In March 2018, the Vietnam-made MR vaccine was incorporated into the Expanded Program on Immunization, and administration of the vaccine to children in Vietnam started. Recently, the MR vaccine was utilized during epidemics among people including adults.
This activity has been highly regarded in Vietnam, and earned the Vietnamese Minister of Health's "Certificate of Good Performance Award" in September 2017, which is the most prestigious award for achievements in Vietnamese healthcare.

 

read more ...

Activity of “Improving Adolescent Sexual & Reproductive Healthcare in Yen Bai province” project in March

From March 12 to 14, 2024, a delegation of representatives of the Embassy of Japan in Vietnam, Daiichi Sankyo Group Japan, and Daiichi Sankyo Vietnam Co., Ltd visited Yen Bai province. The trip is part of the activities of the project "Improving Adolescent Sexual & Reproductive Healthcare in Yen Bai province "  implemented by Save the Children.

 

On the first working day, the delegation visited Van Chan District Health Center; visited 01 private clinic specializing in obstetrics and gynecology - family planning in Tran Phu Farm Town, Van Chan District. In the afternoon of the same day, the delegation visited and participated in a communication event at Van Chan High School. Here, information and knowledge about adolescent sexual and reproductive health care was conveyed in many forms lively and interesting such as: organizing the contest "Ring the Golden Bell", painting contest... revolving around the topic of adolescent sexual and reproductive health care. The event attracted the enthusiastic participation of the teachers as well as all students at Van Chan High School.

 

read more ...

"Improving Adolescent Sexual & Reproductive Healthcare in Yen Bai province” project launching workshop

On July 4th, 2023, in Yen Bai province, Save the Children and Daiichi Sankyo, in collaboration with the Department of Health, Pediatric and Obstetrics Hospital of Yen Bai province, organized the “Improve Adolescent Sexual and Reproductive Health Services in Yen Bai province” project launching workshop with the participation of more than 70 delegates, including: Staff of Save the Children, Representatives of donor (Daiichi Sankyo), The Deputy Director of the Department of Health was also in attendance, Department of Education and Training, Provincial Women's Union, Yen Bai Provincial Youth Union, Department of Finance,...

The project aims to protect maternal and child health in the mountainous area of northern Vietnam where many ethnic minority groups reside. Moreover, making great efforts to improve the situation regarding Adolescent Sexual and Reproductive Healthcare Services and has encouraged people to be equipped with sexual and reproductive knowledge and skills.

 

read more ...

DSVN and Ajinomoto Vietnam Collaboration

On December 20th, 2023, Daiichi Sankyo Vietnam Company Limited (“DSV”) and Ajinomoto Vietnam Co., Ltd., (“AVN”) signed the Memorandum of Cooperation in developing special menus for ALS patients. Through this MOU, both parties express concern about helping ALS patients have delicious meals by developing special menus for and taking care of ALS patients as a matter of mutual interest.

 From the beginning of August 2023, AVN began looking for experts who could advise on necessary nutrition standards and other necessary standards for ALS patients as well as advice related to the suitable structure of menu in a day, menu frame (name of each dish), proper thickening agent. In addition, seeking expert opinions on developing detailed menus or tasting trials is one of the aspects which both parties focus on.

 

read more ...

Opening New Office in Ha Noi

On 09 January 2024, Daiichi Sankyo Vietnam Co., Ltd. has established its new business location in Ha Noi for further expansion of business in Vietnam.

The new office aims to broaden and adding reliance to our position in the capital city and north of Vietnam. This new strength has promoted us to focus more energy on the promotion to be the medical partner of healthcare professionals and closer communications with regulatory authorities.

 

read more ...

Operation of Long An warehouse.

Our journey toward building a high-standard pharmaceutical storage facility began in May 2021 with the construction of our air-conditioned (AC) warehouse, specifically designed to maintain storage conditions between 15-25°C. By October 2022, the facility successfully obtained the Good Storage Practices (GSP) license from the Drug Administration of Vietnam, allowing us to officially launch operations in December 2022. Located in Vinh Loc 2 Industrial Park, Long An Province, Vietnam, and covering an area of 500m², our warehouse is designed to streamline our import and export operations while ensuring the standards of Daiichi Sankyo Group and compliance with local regulations.

read more ...